Back

Effect of empagliflozin on adenosine triphosphate levels in vivo in patients with type 2 diabetes mellitus combined with heart failure

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: New analyses and usage of old drugs Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Uulkan Omurzakova

Kyrgyz State Medical Academy, Bishkek (Kyrgyzstan)

5 More presentations in this session

Presentation thumbnail
Vericiguat and cardiovascular outcomes in heart failure revisited: a bayesian reanalysis of 12,877 patients
Mr P. Batista (BR)
Abstract
Presentation thumbnail
Ambulatory milrinone in advanced heart failure: a single-center comparison of continuous and intermittent infusion strategies
Doctor A. Rioux (Quebec, CA)
Abstract
Presentation thumbnail
Long‑acting efficacy of oral stabilized bivalent liposomal iron therapy on iron balance and quality of life in chronic heart failure: more than iron supplementation
Doctor E. Tagliamonte (Nocera Inferiore, IT)
Abstract
Presentation thumbnail
Effects of low-dose dapagliflozin on heart failure–related outcomes in patients with heart failure and type 2 diabetes: a subanalysis of the dapper study
Doctor S. Ito (Osaka, JP)
Abstract
Presentation thumbnail
Short‑ and long‑term efficacy of oral stabilized bivalent liposomal iron versus intravenous ferric carboxymaltose in chronic heart failure patients: is there a difference?
Professor E. Tagliamonte (Nocera Inferiore, IT)
Abstract

Access the full session

Session thumbnail
New analyses and usage of old drugs

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial
20 May 2023
thumbnail
Congress Presentation
Determinants of left ventricular ATP availability measured in vivo and ex vivo in patients with severe aortic stenosis: correlation of creatine kinase activity with LVEF and ATP diffusion distance
1 September 2019
thumbnail
Congress Presentation
Influence of long-term sodium-glucose cotransporter 2 inhibition on cardiac remodeling in rats with type 1 diabetes mellitus
27 August 2022
thumbnail
Congress Presentation
Energy metabolism in patients with heart failure and atrial fibrillation
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources